Organization · Venture Capital
Kairos Ventures
Kairos Ventures is an investment organization based in Beverly Hills that focuses on early-stage companies in life sciences and physical sciences, primarily emerging from academic research. They support the commercialization of scientific discoveries into viable businesses.
Overview
What Kairos Ventures does
What Kairos Ventures is
Kairos Ventures is an investment organization based in Beverly Hills that focuses on early-stage companies in life sciences and physical sciences, primarily emerging from academic research. They support the commercialization of scientific discoveries into viable businesses.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Kairos Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kairos Ventures as a funder
Investment thesis
Kairos Ventures focuses on transforming scientific discoveries from leading universities into viable businesses, primarily in life sciences and physical sciences.
Focus narrative
The organization primarily invests in early-stage companies within the life sciences and physical sciences sectors. With investments ranging from $150,000 to $20 million, Kairos Ventures aims to back world-class scientists and entrepreneurs, transforming innovative ideas into impactful businesses.
Value beyond capital
Kairos Ventures adds value to its portfolio companies by providing not only capital but also strategic support through a network of experienced professionals. This hands-on approach helps companies navigate the complexities of commercialization and accelerates their growth trajectory.
Terms and economics
- Typical check
- $150,000–$20,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 51
- Recorded notable exits
- Mammoth Biosciences, Actuate Therapeutics, and MixComm
Portfolio context
Kairos Ventures boasts a diverse portfolio of over 51 active companies, including notable names such as Mammoth Biosciences, a leader in CRISPR diagnostics, and Actuate Therapeutics, which focuses on clinical-stage therapeutics for high-impact cancers. Other portfolio highlights include Clearsense, a cloud-based healthcare data platform, and Foldax, known for its synthetic polymer heart valves.
Common questions
What to know about Kairos Ventures
Upseed classifies Kairos Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.